AIMS: To analyse the entity specific incidence and disease specific survival (DSS) of non-Hodgkin lymphomas (NHLs) in Tyrol/Austria, 1991-2000. METHODS: Data from 1307 NHLs (excluding primary cutaneous lymphomas and monoclonal gammopathies of undetermined significance) were obtained. Current status was available for all patients. Except for 29 cases of small lymphocytic (CLL/SLL), lymphoblastic leukaemia (ALL), and myeloma (MM), which were diagnosed cytologically, diagnoses were reclassified on paraffin wax embedded archival material according to new World Health Organisation criteria. Sex specific age adjusted standardised incidence rates were computed using Segi's population weighting. Annual incidence changes were calculated by weighted least square regression analysis. Survival was estimated by the Kaplan-Meier method and compared by log rank test. RESULTS: NHL more frequently affected men (male/female ratio, 1.52). Mean age of occurrence was 61 and 66 years for men and women, respectively. The incidence rate of 14.3 remained constant. There was a significant increase in diffuse large B cell lymphoma (DLBCL) and decrease in CLL/SLL in men, and a decrease in MM in women. Overall DSS was 64% during the mean follow up (43 months). Age, T-NHL, lambda light chain restriction in MM, and male sex in CLL/SLL were associated with poor prognosis. In B-NHL, DSS decreased in the following order: hairy cell leukaemia, marginal zone lymphoma, follicular lymphoma, Burkitt lymphoma, ALL, DLBCL, CLL, MM, and mantle cell lymphoma. CONCLUSIONS: The incidence of NHL in Tyrol has changed in the past decade, with a significant increase in DLBCL, decrease in CLL/SLL in men, and decrease in MM in women.
AIMS: To analyse the entity specific incidence and disease specific survival (DSS) of non-Hodgkin lymphomas (NHLs) in Tyrol/Austria, 1991-2000. METHODS: Data from 1307 NHLs (excluding primary cutaneous lymphomas and monoclonal gammopathies of undetermined significance) were obtained. Current status was available for all patients. Except for 29 cases of small lymphocytic (CLL/SLL), lymphoblastic leukaemia (ALL), and myeloma (MM), which were diagnosed cytologically, diagnoses were reclassified on paraffin wax embedded archival material according to new World Health Organisation criteria. Sex specific age adjusted standardised incidence rates were computed using Segi's population weighting. Annual incidence changes were calculated by weighted least square regression analysis. Survival was estimated by the Kaplan-Meier method and compared by log rank test. RESULTS: NHL more frequently affected men (male/female ratio, 1.52). Mean age of occurrence was 61 and 66 years for men and women, respectively. The incidence rate of 14.3 remained constant. There was a significant increase in diffuse large B cell lymphoma (DLBCL) and decrease in CLL/SLL in men, and a decrease in MM in women. Overall DSS was 64% during the mean follow up (43 months). Age, T-NHL, lambda light chain restriction in MM, and male sex in CLL/SLL were associated with poor prognosis. In B-NHL, DSS decreased in the following order: hairy cell leukaemia, marginal zone lymphoma, follicular lymphoma, Burkitt lymphoma, ALL, DLBCL, CLL, MM, and mantle cell lymphoma. CONCLUSIONS: The incidence of NHL in Tyrol has changed in the past decade, with a significant increase in DLBCL, decrease in CLL/SLL in men, and decrease in MM in women.
Authors: H L Howe; P A Wingo; M J Thun; L A Ries; H M Rosenberg; E G Feigal; B K Edwards Journal: J Natl Cancer Inst Date: 2001-06-06 Impact factor: 13.506
Authors: Tongzhang Zheng; Aaron Blair; Yawei Zhang; Dennis D Weisenburger; Shelia H Zahm Journal: J Occup Environ Med Date: 2002-05 Impact factor: 2.162
Authors: R Forstpointner; A Hänel; R Repp; S Hermann; B Metzner; C Pott; F Hartmann; F Rothmann; H P Böck; H Wandt; M Unterhalt; W Hiddemann Journal: Dtsch Med Wochenschr Date: 2002-10-25 Impact factor: 0.628
Authors: J R Cerhan; R B Wallace; F Dick; J Kemp; A S Parker; W Zheng; T A Sellers; A R Folsom Journal: Cancer Epidemiol Biomarkers Prev Date: 2001-04 Impact factor: 4.254
Authors: Djamila E Issa; Saskia A M van de Schans; Martine E D Chamuleau; Henrike E Karim-Kos; Marielle Wondergem; Peter C Huijgens; Jan Willem W Coebergh; Sonja Zweegman; Otto Visser Journal: Haematologica Date: 2014-12-15 Impact factor: 9.941
Authors: Sylvia Hoeller; Yi Zhou; Rashmi Kanagal-Shamanna; Zijun Y Xu-Monette; Daniela Hoehn; Michel Bihl; Steven H Swerdlow; Andreas Rosenwald; German Ott; Jonathan Said; Cherie H Dunphy; Carlos E Bueso-Ramos; Pei Lin; Michael Wang; Roberto N Miranda; Alexander Tzankov; L Jeffrey Medeiros; Ken H Young Journal: Hum Pathol Date: 2012-08-31 Impact factor: 3.466